Recruiting

Mind-body Resilience Program for Cardiac Arrest Survivors and Their Caregivers: Recovering Together After Cardiac Arrest

The purpose of this study is to pilot two resilience interventions for cardiac arrest survivors and their informal caregivers, Recovering Together after Cardiac Arrest 1 and Recovering Together after Cardiac Arrest 2 . The data the investigators gather in this study will be used to further refine the interventions.

ClinicalTrials.gov IDNCT07143357

PhaseNA

Enrollment84

SponsorIcahn School of Medicine at Mount Sinai

Age18 Years and older

SexALL

I'm interested View official listing

Conditions studied

Emotional Distress, Cardiac Arrest (CA), Anxiety, Depression, Caregivers, Survivorship, Resilience, Mindfulness

About this study

Interventions

Behavioral: Recovering Together after Cardiac Arrest 1 — The intervention will teach resiliency skills (mindfulness and coping) to dyads and provider anticipatory guidance and resources to manage stressors specific to cardiac arrest. These sessions will take place in person until the survivor is discharged; remaining sessions will occur over Zoom.
Other: Recovering Together after Cardiac Arrest 2 — In this minimally enhanced usual care control, dyads will participate in one 30-minute session with a clinician at beside to review a pamphlet of available psychosocial resources for cardiac arrest survivors and their caregivers.

Primary outcomes

Feasibility of Recruitment (pre-test)
Feasibility of Randomization (The end of treatment at 6 weeks)
Feasibility of Assessment Completion (pre-test, the end of treatment at 6 weeks, and 3 months after the end of treatment)
Feasibility of Program Adherence (RT-CA 1) (the end of treatment at 6 weeks)
Therapist Fidelity (the end of treatment at 6 weeks)
Treatment Satisfaction (RT-CA 1) (the end of treatment at 6 weeks)
Credibility (RT-CA 1) (pre-test)
Expectancy (RT-CA 1) (pre-test)

Eligibility information

Inclusion Criteria: * Out-of-hospital or in-hospital CA survivor (must have new diagnosis of "cardiac arrest" in electronic medical record from index hospitalization with documented loss of pulse) with an identified caregiver (identified by the survivor who is their primary source of emotional and functional support) * survivor must score \>5 on Short Form of the Mini Mental State Exam for sufficient cognitive function for meaningful participation * ability and willingness to participate in a hybrid in-person/live video intervention * English speaking adults (18 year or older) * at least one member of the dyad endorses clinically significant emotional distress during screening (\>7 on either of the Hospital Anxiety and Depression Scale subscales). Exclusion Criteria: * active psychosis, mania, substance dependence, or suicidal intent or plan that would require a higher level of care * any other psychiatric or neurological condition that would preclude meaningful participation * the caregiver must not be a cardiac arrest survivor

Study locations

Massachusetts General Hospital, Boston, Massachusetts 02114 United States
Mount Sinai Health System, New York, New York 10029 United States

Before you participate: Varda Clinical is an independent discovery tool, not the study sponsor or a medical provider. Eligibility can only be determined by the official study team. Discuss potential risks and benefits with a qualified healthcare professional.

Source: ClinicalTrials.gov. Record last refreshed by Varda Clinical: 2026-10-21.